The arrival of fraternal twins from Long Island, NY, marked the birth of the 10,000th (and one) baby successfully conceived through in vitro fertilization (IVF) at the Center for Reproductive Medicine and Infertility (CRMI) at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, one of the few centers worldwide to achieve such a milestone. Helping couples make their dreams of becoming parents a reality has been the cornerstone of the Center since its inception in 1989.

Children's Hospital of NewYork-Presbyterian/Weill Cornell has appointed three new Division Chiefs: Chief of the Division of Newborn Medicine, Chief of the Division of Pediatric Gastroenterology and Nutrition, and Chief of the Division of General Academic Pediatrics.

A purified mixture of human antibodies called intravenous immunoglobulin (IVIg) provides lasting benefits to patients with Alzheimer's disease (AD), according to researchers at the NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The clinical study is the first to demonstrate that IVIg stabilizes or improves cognitive function in Alzheimer patients when administered over a period of a year or more.

Surgeons at NewYork-Presbyterian/Weill Cornell performed the world's first gene therapy for Parkinson's disease on a 55-year-old New York man on Monday, August 18.

Love is in the air, but Valentine's Day shouldn't be the only time to express love for your partner; rather, it should serve as a reminder to devote time and energy to your relationship every day.

New research has shown that reducing the dosage of dopamine agonist (DA) drugs, a mainstay treatment for Parkinson's disease (PD), sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts, including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications. For the first time, researchers have defined this phenomenon, which they call dopamine agonist withdrawal syndrome, or DAWS. Led by a physician-scientist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the study is reported in the Jan. 11 Archives of Neurology.

A $6 million grant from the National Heart, Lung and Blood Institute (NHLBI) has funded the creation of ORBIT: Obesity Related Behavioral Intervention Trials to focus on reducing obesity and obesity-related deaths in New York City's African-American and Latino communities.

In recognition of their leadership in clinical care, research and medical education, Dr. Antonio M. Gotto Jr., dean of Weill Cornell Medical College, and Dr. Herbert Pardes, president and CEO of NewYork-Presbyterian Hospital, were each honored yesterday with the Maurice R. Greenberg Distinguished Service Award.